METOTREXATO

Basic Information

Item Value
DrugBank ID DB00563
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 30

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 lymphosarcoma TxGNN Knowledge Graph
2 folliculotropic mycosis fungoides TxGNN Knowledge Graph
3 mantle cell lymphoma TxGNN Knowledge Graph
4 localized pagetoid reticulosis TxGNN Knowledge Graph
5 mycosis fungoides and variants TxGNN Knowledge Graph
6 juvenile idiopathic arthritis TxGNN Knowledge Graph
7 psoriasis TxGNN Knowledge Graph
8 head and neck cancer TxGNN Knowledge Graph
9 bone osteosarcoma TxGNN Knowledge Graph
10 Langerhans cell histiocytosis TxGNN Knowledge Graph
11 lymphoma, non-Hodgkin, familial TxGNN Knowledge Graph
12 non-Hodgkin lymphoma TxGNN Knowledge Graph
13 rheumatoid arthritis TxGNN Knowledge Graph
14 acute lymphoblastic leukemia (disease) TxGNN Knowledge Graph
15 B-cell neoplasm TxGNN Knowledge Graph
16 Burkitt lymphoma TxGNN Knowledge Graph
17 upper aerodigestive tract neoplasm TxGNN Knowledge Graph
18 precursor T-cell acute lymphoblastic leukemia TxGNN Knowledge Graph
19 primary cutaneous T-cell lymphoma TxGNN Knowledge Graph
20 lung neoplasm TxGNN Knowledge Graph
21 gestational trophoblastic neoplasm TxGNN Knowledge Graph
22 parapsoriasis TxGNN Knowledge Graph
23 granulomatous slack skin disease TxGNN Knowledge Graph
24 spondyloarthropathy TxGNN Knowledge Graph
25 lung cancer TxGNN Knowledge Graph
26 juvenile arthritis due to defect in LACC1 TxGNN Knowledge Graph
27 leukemia, lymphocytic, susceptibility to TxGNN Knowledge Graph
28 acute lymphoblastic/lymphocytic leukemia TxGNN Knowledge Graph
29 lymphoma TxGNN Knowledge Graph
30 female breast carcinoma TxGNN Knowledge Graph

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search